Advancements in Oral Cancer Therapeutics Using Long Non-coding RNAs
Biomedical & Pharmacology Journal · 26.06.2026 · 2 (19) · 2036
DOI: 10.13005/bpj/3477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 25.06.2026. Verfasst von Subhayan Sur. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Govt. of India, Prime Minister’s Early Career Research Grant.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) remains a major global health burden with limited therapeutic success. Advances in transcriptomic profiling have identified long non-coding RNAs (lncRNAs) as key regulators of OSCC progression and therapy resistance. This short communication summarizes recent developments in lncRNA-based therapeutic strategies identified through focused literature analysis using PubMed, Google Scholar, and ClinicalTrials.gov. Preclinical evidence from xenograft and patient-derived xenograft models demonstrates the potential of antisense oligonucleotides, RNA interference, CRISPR-based genome modulation, and exosome-mediated delivery to silence oncogenic lncRNAs or restore tumor-suppressive lncRNAs. Although clinical translation remains early, these findings highlight emerging precision therapeutic opportunities in OSCC.
Förderung
- Department of Biotechnology, Govt. of India
- Prime Minister’s Early Career Research Grant
Zitieren
APA
Sur, S. (2026). Advancements in Oral Cancer Therapeutics Using Long Non-coding RNAs. Biomedical & Pharmacology Journal, 2(19), 2036. https://doi.org/10.13005/bpj/3477
Vancouver
Sur S. Advancements in Oral Cancer Therapeutics Using Long Non-coding RNAs. Biomedical & Pharmacology Journal. 2026;2(19):2036. doi:10.13005/bpj/3477
BibTeX
@article{Sur2026,
author = {Sur, Subhayan},
title = {Advancements in Oral Cancer Therapeutics Using Long Non-coding RNAs},
journal = {Biomedical & Pharmacology Journal},
year = {2026},
volume = {2},
number = {19},
pages = {2036},
doi = {10.13005/bpj/3477}
}
EUVIMED